Pharmaceutical Enterprise LEK-AM Ltd.
PolandAll medications by this manufacturer
-
Memolek
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 10 mg ATC: N06DX01
-
Memolek
Form: tablets, film-coated
Active substance Dosage memantine hydrochloride 20 mg ATC: N06DX01
-
Montelukast lek-am
Form: tablets, chewable
Active substance Dosage sodium montelukast 5 mg ATC: R03DC03
-
Montelukast lek-am
Form: tablets, film-coated
Active substance Dosage montelukast 10 mg ATC: R03DC03
-
Montelukast lek-am
Form: tablets, chewable
Active substance Dosage montelukast 4 mg ATC: R03DC03
-
Nobaxin
Form: tablets, film-coated
Active substance Dosage Azithromycin 500 mg ATC: J01FA10
-
Nonpres duo
Form: tablets
Active substance Dosage eplerenone 25 mg furosemide 40 mg ATC: C03EB01
-
Nonpres duo
Form: tablets
Active substance Dosage Eplerenone 50 mg Furosemide 40 mg ATC: C03EB01
-
Olmesartan lek-am
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
-
Olmesartan lek-am
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
-
Ostolek
Form: tablets, film-coated
Active substance Dosage Sodium alendronate trihydrate No input provided ATC: M05BA04
-
Pulmoterol
Form: powder for inhalation in hard capsules
Active substance Dosage Salmeterol 0.05 mg ATC: R03AC12
-
Risperon
Form: tablets, film-coated
Active substance Dosage risperidone 4 mg ATC: N05AX08
-
Risperon
Form: tablets, film-coated
Active substance Dosage risperidone 1 mg ATC: N05AX08
-
Risperon
Form: tablets, film-coated
Active substance Dosage risperidone 3 mg ATC: N05AX08
-
Risperon
Form: tablets, film-coated
Active substance Dosage risperidone 2 mg ATC: N05AX08
-
Rivaroxaban lek-am
Form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
Rivaroxaban lek-am
Form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
Rivaroxaban lek-am
Form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01
-
Senaxa pr
Form: tablets, prolonged release
Active substance Dosage Melatonin 2 mg ATC: N05CH01
-
Subinit
Form: capsules, hard
Active substance Dosage sunitinib 12.5 mg ATC: L01EX01
-
Subinit
Form: capsules, hard
Active substance Dosage sunitinib 25 mg ATC: L01EX01
-
Subinit
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
-
Trimeductan mr
Form: tablets, modified release
Active substance Dosage trimetazidine dihydrochloride 35 mg ATC: C01EB15